These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17495819)

  • 21. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Zaromitidou M; Kioufis S; Maniatis K; Dilaveris P; Miliou A; Michalea S; Papavassiliou AG; Stefanadis C
    Atherosclerosis; 2013 Apr; 227(2):367-72. PubMed ID: 23433403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atorvastatin on vascular endothelial function in moderately nicotine-dependent smokers.
    Cao XZ; Luo ZR; Zhang HM; Cai JQ
    Genet Mol Res; 2014 Apr; 13(2):2698-702. PubMed ID: 24782083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.
    Tan KC; Chow WS; Tam SC; Ai VH; Lam CH; Lam KS
    J Clin Endocrinol Metab; 2002 Feb; 87(2):563-8. PubMed ID: 11836286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of atorvastatin on impaired vascular function in healthy old men.
    Weverling-Rijnsburger AW; Blauw GJ; Meinders AE
    J Clin Pharm Ther; 2004 Apr; 29(2):157-64. PubMed ID: 15068405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics.
    Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP
    Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery.
    Shah SJ; Waters DD; Barter P; Kastelein JJ; Shepherd J; Wenger NK; DeMicco DA; Breazna A; LaRosa JC
    J Am Coll Cardiol; 2008 May; 51(20):1938-43. PubMed ID: 18482661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.
    van Venrooij FV; van de Ree MA; Bots ML; Stolk RP; Huisman MV; Banga JD;
    Diabetes Care; 2002 Jul; 25(7):1211-6. PubMed ID: 12087021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia].
    Balakhonova TV; Pogorelova OA; Susekov AV; Kobylianskiĭ AG; Kuznetsova TV; Tvorogova MG; Masenko VP; Titov VN; Kukharchuk VV; At'kov OIu
    Kardiologiia; 2002; 42(1):15-21. PubMed ID: 12494218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)].
    Noseda G; Darioli R; Keller U; Mordasini R; Shokry A; Schaffhauser B; Riesen W
    Schweiz Med Wochenschr; 2000 Jun; 130(23):889-95. PubMed ID: 10897490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia].
    Nikitina NM; Rebrov AP
    Kardiologiia; 2009; 49(9):21-6. PubMed ID: 19772499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
    Charbonneau F; Anderson TJ; Title L; Jobin J; Poirier P; Huyhn T; Chan S; Walling A; Hutchison S; Tran T; Lonn E; Buithieu J; Genest J
    Atherosclerosis; 2008 Mar; 197(1):420-7. PubMed ID: 17673219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
    JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
    Ostad MA; Eggeling S; Tschentscher P; Schwedhelm E; Böger R; Wenzel P; Meinertz T; Munzel T; Warnholtz A
    Atherosclerosis; 2009 Jul; 205(1):227-32. PubMed ID: 19150064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease.
    Inanc MT; Kalay N; Heyit T; Ozdogru I; Kaya MG; Dogan A; Duran M; Kasapkara HA; Gunebakmaz O; Borlu M; Yarlıoglues M; Oguzhan A
    Echocardiography; 2010 Sep; 27(8):997-1003. PubMed ID: 20545993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative assessment of antiinflammatory action of atorvastatin in ischemic heart disease and rheumatoid arthritis].
    Tutunov VS; Popkova TV; Novikova DS; Nasonov EL; Kukhrchuk VV
    Kardiologiia; 2008; 48(9):4-8. PubMed ID: 18991814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.